about
Pancreatic β Cell Mass DeathAssessment of pancreatic β-cell function: review of methods and clinical applicationsEffects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgeryNatural history of β-cell adaptation and failure in type 2 diabetesNkx6.1 regulates islet β-cell proliferation via Nr4a1 and Nr4a3 nuclear receptorsPrevention of obesity and diabetes in childbearing women.Advantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test.Circulating ferritin concentrations and risk of type 2 diabetes in Japanese individuals.Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study.Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humansThe isolated pancreatic islet as a micro-organ and its transplantation to cure diabetes: celebrating the legacy of Paul Lacy.New approach to beta cell function screening by nitric oxide assessment of obese individuals at the population level.Physical exercise and pancreatic islets: acute and chronic actions on insulin secretionRisk factors for type 2 diabetes mellitus preceded by β-cell dysfunction, insulin resistance, or both in older adults: the Cardiovascular Health Study.Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes.Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe.Cardiac autonomic function evaluated by the heart rate turbulence method was not changed in obese patients without co-morbiditiesHigh Fat Diet Regulation of β-Cell Proliferation and β-Cell Mass.Is serum zinc associated with pancreatic beta cell function and insulin sensitivity in pre-diabetic and normal individuals? Findings from the Hunter Community Study.Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis.Postprandial but not fasting insulin resistance is an early identifier of dysmetabolism in overweight subjects.Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6.Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls.Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice.Quantification of the relationship between glycemia and beta-cell mass adaptation in vivo.Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity.Effects of a hypercaloric diet on β-cell responsivity in lean healthy men.Going with the flow: adaptation of β-cell function to glucose fluxes after bariatric surgery.Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men.Correlations of HOMA2-IR and HbA1c with algorithms derived from bioimpedance and spectrophotometric devices.Effect of avocado soybean unsaponifiables on insulin secretion and insulin sensitivity in patients with obesity.Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumor.Improved glycemic control with proximal intestinal bypass and weight loss following gastrectomy in non-obese diabetic gastric cancer patients.Parent-of-origin specific linkage and association of the IGF2 gene region with birth weight and adult metabolic risk factors.Weight Regain After Gastric Bypass: Influence of Gut Hormones.C-peptide levels and the risk of diabetes and pre-diabetes among Chinese women with gestational diabetes.Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects.Independent relationships of obesity and insulin resistance with serum proinsulin level in prepubertal children with normal glucose tolerance.Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.Influence of organ donor attributes and preparation characteristics on the dynamics of insulin secretion in isolated human islets.
P2860
Q26752571-5ED33708-AFBF-46AF-A2EF-CB562810E642Q26829445-24D2BE94-0EF0-4214-8DF0-16E60230CE96Q26995145-709B4F49-CB81-49A8-B957-B71D1ED6098EQ28082002-DB73CE60-58E1-453B-A42B-8BD38774337CQ28578613-0D7D1AAD-A2E2-44CA-A826-DE81156834BFQ30430192-3C81E5FE-95F4-4409-9EDC-93DEA4AE9054Q33804310-1E3B3A74-3AC8-4805-97DA-3F2629AB9CE7Q33871390-B02EC277-6827-4210-9E8E-3796102BA08DQ34204342-EA9A20AF-DB13-4BCA-818D-6EFD99915FF1Q35179981-CD3AB783-92E4-4F9C-9F21-B41F8CE31765Q35878665-2227F033-57A4-4E31-9BCC-340AAEBCD05EQ36008854-C2DC85BA-514F-4391-A496-55D831750A77Q36394681-C4836200-B868-4089-B889-1829694FE585Q36999932-4E68C41D-87FE-4708-A1B4-0AC78FE07B7FQ37105254-22D52598-DBAF-4C64-BB46-7E1E503E41BCQ37212797-B6B5ADA1-B8CC-41DF-BB5B-131D5ACE10BEQ37221068-D2A580FB-8DBF-4A0A-A422-83536880E5F1Q37377320-F9D16857-BDC9-4016-91A2-A4720782DE33Q37452590-AF182CDD-0235-4664-984F-E4B338AFB926Q38296029-6F8D42CE-1C60-49AC-A438-6F615D42240CQ38469445-829FC769-0C03-420D-9F1A-2BBF96A84648Q40354541-BB7F6503-F9C3-4177-93DA-8BFBF1859CD2Q41480990-CD07073F-63F1-43E3-83D3-C06C77D8BBCDQ41854974-1858B4EC-B36F-4D69-A855-3F44623C1896Q42460121-13AE10A7-4C94-4AE4-8F85-B61B20179E29Q42467853-49E7BFC4-A68C-4513-802A-89E970F5BEC7Q42501927-96C12357-369C-4DA9-B101-124FD7343270Q42936637-A9A8B38D-4580-4167-AE4E-B4089B1F91EEQ44985760-A3CE6B20-0073-47CB-BFBD-85FC24033D40Q45252723-6248D823-5218-4EAD-BA4B-9869276D3E06Q45573452-274FFD88-A30F-454C-A2AA-A62C3C9BF7E4Q46960288-C4E14BA5-D5F1-4EBA-9855-FC369B24129AQ47173393-17D9A8C7-0449-4A1C-8903-1D02ABCF91B6Q47179167-4A81613E-56D3-43E6-B727-BB76FB65C98DQ47355415-7F14A907-17A4-45CE-87FF-D42BDB3D016CQ50053135-FF1D713B-2648-4302-8DDC-13B25DC6C38AQ51378475-C2D325E2-B079-4374-AE3B-D7F557481B4BQ51382361-090E80CF-5750-4B91-B643-E8E326B031BEQ51474253-64668272-7202-4DF4-9DC7-47438062DA92Q52656651-1A7D6A33-E91C-445C-8C93-F480DFD0E75E
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
beta-cell function in obesity: effects of weight loss.
@ast
beta-cell function in obesity: effects of weight loss.
@en
type
label
beta-cell function in obesity: effects of weight loss.
@ast
beta-cell function in obesity: effects of weight loss.
@en
prefLabel
beta-cell function in obesity: effects of weight loss.
@ast
beta-cell function in obesity: effects of weight loss.
@en
P2093
P50
P1433
P1476
beta-cell function in obesity: effects of weight loss
@en
P2093
Andrea Mari
Anna Maria Sironi
Ele Ferrannini
Geltrude Mingrone
P304
P356
10.2337/DIABETES.53.SUPPL_3.S26
P407
P478
53 Suppl 3
P577
2004-12-01T00:00:00Z